Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaim A Schramm

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|January 13, 2025
Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Immunity|April 6, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.
Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Cell Reports|January 30, 2026
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.
Cell|March 8, 2016
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyMattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|January 13, 2025
Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Immunity|April 6, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.
Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Cell Reports|January 30, 2026
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.
Cell|March 8, 2016
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyMattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.
Pageof 6